Supriya Lifescience Ltd. has signed an agreement with Pune based Enrich Energy Pvt Ltd. to develop 4.68 MWp DC Solar Photovoltaic Power project at Site Nanded, Maharashtra.
The Board of Directors of Supriya Lifescience Limited have approved the financial results of the company for the period ended September 30, 2022 - Q2FY23, H1FY23 at its board meeting.
Get latest articles and stories on Business at LatestLY. Supriya Lifescience, an active pharmaceutical ingredients manufacturer, made a strong debut at the stock market on Tuesday with its share getting listed at 55 per cent premium over its issue price of Rs.274 per share. Business News | Supriya Lifescience Makes Stock Market Debut at 55 Per Cent Premium.
Supriya Lifescience, an active pharmaceutical ingredients manufacturer, made a strong debut at the stock market on Tuesday with its share getting listed at 55 p